Table 4.
Assessment of reperfusion achieved with ppci
| TIMI/MBG GRADES | Tirofiban (%) ¶ | Placebo (%) Ω | p |
|---|---|---|---|
| TIMI PRE-PPCI | 0-2 x 3 | ||
| 0 | 22 (91.6%) | 29 (85.3%) | (=1.00) ƒ |
| 1 | 0(0%) | 1 (2.9%) | |
| 2 | 2 (8.3%) | 2(5.8%) | |
| 3 | 0(0%) | 2 (5.8%) | |
| TIMI POST-PPCI | 0-2 x 3 | ||
| 0 | 0(0%) | 0(0%) | (=0.40) ƒ |
| 1 | 0(0%) | 1 (2.9%) | |
| 2 | 6 (25%) | 12 (35.3%) | |
| 3 | 18 (75%) | 21 (61.7%) | |
| MBG PRE-PPCI | 0-1 x 2-3 | ||
| 0 | 22 (91.6%) | 29 (85.3%) | (=1.00) ƒ |
| 1 | 0 (0%) | 2 (5.8%) | |
| 2 | 2 (8.3%) | 0 (0%) | |
| 3 | 0 (0%) | 3 (8.8%) | |
| MBG POST-PPCI | 0–1 x 2–3 | ||
| 0 | 0 (0%) | 0 (0%) | (=0.13) ƒ |
| 1 | 0(0%) | 4 (11.7%) | |
| 2 | 11 (45.8%) | 10 (29.4%) | |
| 3 | 13 (54.2%) | 20 (58.8%) | |
| ECG/STR | 90 min | 90 min | |
| No STR (<30%) | 0(0%) | 9(26.5%) | (=0.01) ƒ |
| STR (71-100%) | 14 (58.3%) | 15 (44.1%) | (=0.42) ƒ |
| ECG/STR | 24h | 24h | |
| NO STR (<30%) | 1(4.2%) | 8 (23.5%) | (=0.06) ƒ |
| STR (71-100%) | 17 (71%) | 15 (44.1%) | (=0.06) ƒ |
TIMI: thrombolysis in myocardial infarction, according to the TIMI Study Group (1985); MBG: myocardial blush grade, according to the Zwolle Myocardial Infarction Study Group (VAN’T HOF AW ,1998); PPCI: primary percutaneous coronary intervention; ECG: electrocardiogram; STR: ST elevation resolution; No STR: number of ST Elevation resolution
ƒ
comparison of TIMI 0 and 1 versus, TIMI 2 and 3, MBG 0 and 1 versus MBG 2 and 3, and patients with and without STR at 90min and at 24hours by Fisher Exact Test;
Ţ: p-value calculated by Student t-test (95%IC,0.32-31.28);
¶
tirofiban percentage;
Ω
placebo percentage.